All News

The injured dancer needs to perform on closing night; the physiatrist may need to securely tape an ankle in exchange for a promise that this performance will be the last for a while.

The study revealed disparities in access to crucial kidney transplant and nephrology care for persons with ESKD related to pregnancy vs to other causes.

Your daily dose of the clinical news you may have missed.

Study participants randomized to placebo for 1 year after 36 weeks on tirzepatide had mean weight regain of 14% vs augmented loss among those who continued on the medication.

First-ever vaccines against RSV in older adults, from GSK and Pfizer, won FDA approval in 2023. This brief slide show highlights the year's headline news about both.

Nonmedical exemptions from required school vaccinations accounted for more than 90% of the increase, according to the published data.

Tracy Espiritu McKay, DO, a former musical theater performer, can almost feel her patient's pain. She highlights treatment challenges and says early referral after injury is key.

Your daily dose of the clinical news you may have missed.

Restoration of certain bacteria in the gut microbiome may help ameliorate common symptoms associated with long COVID, according to new research.

Higher intake of omega-3 polyunsaturated fatty acids may reduce the risk for cardiovascular disease in persons with a family history of CVD.

Your daily dose of the clinical news you may have missed.

Speaking about treating mental health symptoms linked to COVID-19 infection, Dr Abby Cheng reiterates the importance of validating the patient's experience.

While incretin-based antiobesity medications are the optimal treatment for some, there are other less costly approaches that can support weight loss success, this author says.

Your daily dose of the clinical news you may have missed.

Among study participants with migraine, investigators observed consistent and persistent device efficacy for pain relief, pain freedom, and functional disability freedom.

Ubrogepant 100 mg taken during the migraine prodrome significantly reduced onset of moderate or severe headache for 24 hours after study-drug dose.

With 3 vaccines approved against pneumococcal disease in adults, is there really the need - or the room - for 1 more? Here's what one physician thinks.

The vaccine has been available in Europe for more than 20 years; the ACIP published recommendations in November. Will any of your patients need it?